2021 US Medicinal Products
Financial Strength Rankings using Artificial Intelligence
Top rated | 13 of 52 |
Best rating | 176 % |
Worst rating | -2,050 % |
New companies | 6 |
Negative Economic Capital Ratio | 17 of 52 |
Financial Strength Rankings using Artificial Intelligence
Top rated | 13 of 52 |
Best rating | 176 % |
Worst rating | -2,050 % |
New companies | 6 |
Negative Economic Capital Ratio | 17 of 52 |
ARCA biopharma Inc. climbed 23 positions from 30 to 7 due to its excellent Assets, Current.Pure Harvest Corporate Group Inc. lost 18 positions from 19 to 37 due to its bad Revenues.Canopy Growth Corp entered the 2021 ranking at rank 16, making it the best newcomer.
Revenues | 34.1 B |
Assets | 65.7 B |
Expenses | 35.7 B |
Stockholders Equity | 30.1 B |
Unprofitable Companies | 38 of 52 |
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2024 ranking for the U.S. Petroleum [...]
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2024 ranking for the U.S. Aviation [...]
🚀 RealRate is raising! At realrate.ai, we’re revolutionizing financial ratings and analytics [...]
Last week, Dr. Holger Bartel, CEO of RealRate, pitched the business, showing how [...]
Earlier in September in Berlin, Dr. Holger Bartel, CEO of RealRate, hosted an [...]
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2024 ranking for the U.S. Life [...]
Source: https://www.germanaccelerator.com Some incredible news at RealRate, folks! We have been [...]
Last week Dr. Holger Bartel, CEO at RealRate, took part in a very [...]
This year's rating information is fee-based. Please request rates at
james.woods@realrate.ai